Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1371/journal.pone.0255417 http://scihub22266oqcxt.onion/10.1371/journal.pone.0255417 34347828!8336808!34347828     free     free     free Deprecated: Implicit conversion from float 227.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\34347828.jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117       PLoS+One 2021 ; 16 (8): e0255417 Nephropedia Template TP {{tp|p=34347828|t=2021. EUAdb: A resource for COVID-19 test development and comparison |pdf=|usr=}}{{34347828}} gab.com Text EUAdb: A resource for COVID-19 test development and comparison JO: PLoS One http://www.kidney.de/pget.php?&tw=1&pmid=34347828 #FOAvip Due to the sheer number of COVID-19 (coronavirus disease 2019) cases there is a need for increased world-wide SARS-CoV-2 testing capability that is both efficient and effective. Having open and easy access to detailed information about these tests, their sensitivity, the types of samples they use, etc. would be highly useful to ensure their reproducibility, to help clients compare and decide which tests would be best suited for their applications, and to avoid costs of reinventing similar or identical tests. Additionally, this resource would provide a means of comparing the many innovative diagnostic tools that are currently being developed in order to provide a foundation of technologies and methods for the rapid development and deployment of tests for future emerging diseases. Such a resource might thus help to avert the delays in testing and screening that was observed in the early stages of the pandemic and plausibly led to more COVID-19-related deaths than necessary. We aim to address these needs via a relational database containing standardized ontology and curated data about COVID-19 diagnostic tests that have been granted Emergency Use Authorizations (EUAs) by the FDA (US Food and Drug Administration). Simple queries of this actively growing database demonstrate considerable variation among these tests with respect to sensitivity (limits of detection, LoD), controls and targets used, criteria used for calling results, sample types, reagents and instruments, and quality and amount of information provided. Twit Text FOAVip EUAdb: A resource for COVID-19 test development and comparison ????PLoS One http://www.kidney.de/pget.php?&tw=1&pmid=34347828 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=34347828 #FOAvip English Wikipedia <ref>{{Cite pmid|34347828}}</ref> EUAdb: A resource for COVID-19 test development and comparison #MMPMID34347828 Woronik A; Shaffer HW; Kiontke K; Laurent JM; Zambrano R; Daley M; Boeke JD; Fitch DHA PLoS One 2021[]; 16 (8): e0255417 PMID34347828show ga Due to the sheer number of COVID-19 (coronavirus disease 2019) cases there is a need for increased world-wide SARS-CoV-2 testing capability that is both efficient and effective. Having open and easy access to detailed information about these tests, their sensitivity, the types of samples they use, etc. would be highly useful to ensure their reproducibility, to help clients compare and decide which tests would be best suited for their applications, and to avoid costs of reinventing similar or identical tests. Additionally, this resource would provide a means of comparing the many innovative diagnostic tools that are currently being developed in order to provide a foundation of technologies and methods for the rapid development and deployment of tests for future emerging diseases. Such a resource might thus help to avert the delays in testing and screening that was observed in the early stages of the pandemic and plausibly led to more COVID-19-related deaths than necessary. We aim to address these needs via a relational database containing standardized ontology and curated data about COVID-19 diagnostic tests that have been granted Emergency Use Authorizations (EUAs) by the FDA (US Food and Drug Administration). Simple queries of this actively growing database demonstrate considerable variation among these tests with respect to sensitivity (limits of detection, LoD), controls and targets used, criteria used for calling results, sample types, reagents and instruments, and quality and amount of information provided. |*COVID-19 Testing/methods/standards[MESH] |*Databases, Factual/supply & distribution[MESH] |*Emergencies/classification[MESH] |COVID-19/diagnosis[MESH] |Data Management/organization & administration/standards[MESH] |Emergency Treatment/classification/methods[MESH] |Humans[MESH] |Internet[MESH] |Laboratories/standards[MESH] |Reference Standards[MESH] |Sensitivity and Specificity[MESH] |United States[MESH] |United States Food and Drug Administration/*organization & administration[MESH]EUAdb: A resource for COVID-19 test development and comparison (epmc).pdf DeepDyve Pubget Overpricing